Loading...
Emerging Markets And Global Aging Will Elevate Biosimilars
AnalystHighTarget's Fair Value
US$14.00
28.7% undervalued intrinsic discount11 Sep
US$9.98
1Y
-15.6%7D
0.1%1Y
-15.6%7D
0.1%You can edit this narrative until Aug 20 9:34 PM. Then, changes will post as Updates.